Expand XNCR Menu
XNCR MENU

XNCR Stock Posts


Unusual Option Volume

XNCR Xencor23.91-1.13 (-4.5%)

Xencor trades 10,536 contracts. The company has the following event: Presentation of new clinical data to support a recommended Phase 3 dose for XmAb819 between Jul 1, 2026 and Dec 31, 2026.
Unusual Option Volume

XNCR Xencor25.77+0.93 (+3.7%)

Xencor trades 2,707 contracts. The company has the following event: Presentation of new clinical data to support a recommended Phase 3 dose for XmAb819 between Jul 1, 2026 and Dec 31, 2026.
Unusual Option Volume

XNCR Xencor25.61+0.61 (+2.4%)

Xencor trades 2,157 contracts. The company has the following event: Presentation of new clinical data to support a recommended Phase 3 dose for XmAb819 between Jul 1, 2026 and Dec 31, 2026.
XNCR #Xencor stock declines -1.9% in after hours trading. See the latest news.

After Hours Decliner

XNCR Xencor19.13-0.76-3.8%

After Hours:18.76-0.37 (-1.9%)

Xencor Announces Proposed Public Offering of Common Stock

Business WireTue, 10-Sep 4:01 PM

XNCR #Xencor stock declines -6.9% in after hours trading. See the latest news.

After Hours Decliner

XNCR Xencor26.52+0.65+2.5%

After Hours:24.70-1.82 (-6.9%)

Xencor Reports Fourth Quarter and Full Year 2023 Financial Results

Business WireTue, 27-Feb 4:01 PM

XNCR #Xencor stock declines -6.9% in after hours trading. See the latest news.

After Hours Decliner

XNCR Xencor26.52+0.65+2.5%

After Hours:24.70-1.82 (-6.9%)

Xencor Reports Fourth Quarter and Full Year 2023 Financial Results

Business WireTue, 27-Feb 4:01 PM

Market Data Delayed 15 Minutes